Derek Maetzold compensation by year
CASTLE BIOSCIENCES Summary Compensation Table · all 8 fiscal years held| Component | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Salary | $409,500 | $769,562 | $550,000 | $625,000 | $660,000 | $686,400 | $715,572 | $751,350 |
| Bonus | $0 | $18,690 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $1,268,982 | $2,500,003 | $6,102,902 | $0 | $5,283,595 | $4,977,208 |
| Option awards | $161,040 | $2,991,141 | $3,056,657 | $2,656,954 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $206,000 | $341,760 | $457,600 | $722,500 | $771,375 | $893,350 | $921,657 | $1,036,863 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $14,218 | $11,200 | $11,400 | $17,400 | $18,300 | $26,234 | $20,250 | $21,350 |
| Total | $790,758 | $4,132,353 | $5,344,639 | $6,521,857 | $7,552,577 | $1,605,984 | $6,941,074 | $6,786,771 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CASTLE BIOSCIENCES INC DEF 14A filed April 8, 2026, accession 0001628280-26-024166, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CASTLE BIOSCIENCES INC filed document, accession 0001628280-26-024166. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 111,948 | $4,354,777 | — |
| RSU | 111,948 | $4,354,777 | — |
| RSU | 93,328 | $3,630,459 | — |
| PSU | 62,218 | $2,420,280 | — |
| RSU | 33,496 | $1,302,994 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in CASTLE BIOSCIENCES INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
181 Form 4 lines since the FY2025 proxy (filed April 8, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-02 | Sale | 10b5-1 | 1,025 | $36.81 | 3,904 |
| 2026-11-02 | Sale | 10b5-1 | 2,816 | $36.01 | 2,024 |
| 2026-11-02 | Sale | 10b5-1 | 2,393 | $36.01 | 1,721 |
| 2026-11-02 | Sale | 10b5-1 | 382 | $36.81 | 1,642 |
| 2026-11-02 | Sale | 10b5-1 | 325 | $36.81 | 1,396 |
| 2026-11-02 | Sale | 10b5-1 | 7,555 | $36.01 | 4,929 |
| 2026-10-19 | Sale | 10b5-1 | 8,580 | $31.91 | 12,484 |
| 2026-10-19 | Sale | 10b5-1 | 2,718 | $31.91 | 4,114 |
The 8 most recent of 181 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
CASTLE BIOSCIENCES’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Derek Maetzold · this page | President and Chief Executive Officer | $6,786,771 |
| Frank Stokes | Chief Financial Officer | $2,419,837 |
| Kristen Oelschlager | Chief Operating Officer | $2,362,571 |
| Tobin Juvenal | Chief Commercial Officer | $2,362,571 |
Board service
CASTLE BIOSCIENCES board · FY2023–FY2025How this board is paid
Company policy: CASTLE BIOSCIENCES pays directors a $50,000 cash retainer and $250,000 in equity. As stated in CASTLE BIOSCIENCES's FY2025 proxy.
The full CASTLE BIOSCIENCES compensation record
free company briefThis page is one person within CASTLE BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CASTLE BIOSCIENCES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CASTLE BIOSCIENCES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CASTLE BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CSTL
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.